Case-control study of phyto-oestrogens and breast cancer - PubMed (original) (raw)
Case-control study of phyto-oestrogens and breast cancer
D Ingram et al. Lancet. 1997.
Abstract
Background: Phyto-oestrogens are a group of naturally occurring chemicals derived from plants; they have a structure similar to oestrogen, and form part of our diet. They also have potentially anticarcinogenic biological activity. We did a case-control study to assess the association between phyto-oestrogen intake (as measured by urinary excretion) and the risk of breast cancer.
Methods: Women with newly diagnosed early breast cancer were interviewed by means of questionnaires, and a 72 h urine collection and blood sample were taken before any treatment started. Controls were randomly selected from the electoral roll after matching for age and area of residence. 144 pairs were included for analysis. The urine samples were assayed for the isoflavonic phyto-oestrogens daidzein, genistein, and equol, and the lignans enterodiol, enterolactone, and matairesinol.
Findings: After adjustment for age at menarche, parity, alcohol intake, and total fat intake, high excretion of both equol and enterolactone was associated with a substantial reduction in breast-cancer risk, with significant trends through the quartiles: equol odds ratios were 1.00, 0.45 (95% CI 0.20, 1.02), 0.52 (0.23, 1.17), and 0.27 (0.10, 0.69)--trend p = 0.009--and enterolactone odds ratios were 1.00, 0.91 (0.41, 1.98), 0.65 (0.29, 1.44), 0.36 (0.15, 0.86)--trend p = 0.013. For most other phytoestrogens there was a reduction in risk, but it did not reach significance. Difficulties with the genistein assay precluded analysis of that substance.
Interpretation: There is a substantial reduction in breast-cancer risk among women with a high intake (as measured by excretion) of phyto-oestrogens-particularly the isoflavonic phyto-oestrogen equol and the lignan enterolactone. These findings could be important in the prevention of breast cancer.
Comment in
- Phyto-oestrogens and breast cancer.
Messina M, Barnes S, Setchell KD. Messina M, et al. Lancet. 1997 Oct 4;350(9083):971-2. doi: 10.1016/S0140-6736(05)64062-7. Lancet. 1997. PMID: 9329507 No abstract available. - Phyto-oestrogens and breast cancer.
Heaton KW, Lewis SJ. Heaton KW, et al. Lancet. 1998 Jan 10;351(9096):137; author reply 138-9. doi: 10.1016/s0140-6736(05)78126-5. Lancet. 1998. PMID: 9439511 No abstract available. - Phyto-oestrogens and breast cancer.
Mangtani P, Silva Idos S. Mangtani P, et al. Lancet. 1998 Jan 10;351(9096):137; author reply 138-9. doi: 10.1016/s0140-6736(05)78125-3. Lancet. 1998. PMID: 9439512 No abstract available. - Phyto-oestrogens and breast cancer.
de Souza RM. de Souza RM. Lancet. 1998 Jan 10;351(9096):137-8; author reply 138-9. doi: 10.1016/s0140-6736(98)26002-8. Lancet. 1998. PMID: 9439513 No abstract available. - Phyto-oestrogens and breast cancer.
Humfrey C. Humfrey C. Lancet. 1998 Jan 10;351(9096):138; author reply 138-9. doi: 10.1016/S0140-6736(05)78124-1. Lancet. 1998. PMID: 9439514 No abstract available. - Phyto-oestrogens and breast cancer.
Tesarik J, Mendoza C. Tesarik J, et al. Lancet. 1998 Jan 10;351(9096):138; author reply 138-9. doi: 10.1016/S0140-6736(05)78123-X. Lancet. 1998. PMID: 9439515 No abstract available. - Phyto-oestrogens and breast cancer.
Bender AE. Bender AE. Lancet. 1998 Jan 10;351(9096):139. doi: 10.1016/s0140-6736(05)78121-6. Lancet. 1998. PMID: 9463149 No abstract available.
Similar articles
- Phyto-oestrogens and breast cancer.
Messina M, Barnes S, Setchell KD. Messina M, et al. Lancet. 1997 Oct 4;350(9083):971-2. doi: 10.1016/S0140-6736(05)64062-7. Lancet. 1997. PMID: 9329507 No abstract available. - Phyto-oestrogen excretion and rate of bone loss in postmenopausal women.
Kardinaal AF, Morton MS, Brüggemann-Rotgans IE, van Beresteijn EC. Kardinaal AF, et al. Eur J Clin Nutr. 1998 Nov;52(11):850-5. doi: 10.1038/sj.ejcn.1600659. Eur J Clin Nutr. 1998. PMID: 9846600 - Urinary isoflavonoid phytoestrogen and lignan excretion after consumption of fermented and unfermented soy products.
Hutchins AM, Slavin JL, Lampe JW. Hutchins AM, et al. J Am Diet Assoc. 1995 May;95(5):545-51. doi: 10.1016/S0002-8223(95)00149-2. J Am Diet Assoc. 1995. PMID: 7722188 Clinical Trial. - Phyto-oestrogens and cardiovascular disease risk.
van der Schouw YT, de Kleijn MJ, Peeters PH, Grobbee DE. van der Schouw YT, et al. Nutr Metab Cardiovasc Dis. 2000 Jun;10(3):154-67. Nutr Metab Cardiovasc Dis. 2000. PMID: 11006924 Review. - Bioavailability of phyto-oestrogens.
Rowland I, Faughnan M, Hoey L, Wähälä K, Williamson G, Cassidy A. Rowland I, et al. Br J Nutr. 2003 Jun;89 Suppl 1:S45-58. doi: 10.1079/BJN2002796. Br J Nutr. 2003. PMID: 12725656 Review.
Cited by
- Exploration of the link between COVID-19 and gastric cancer from the perspective of bioinformatics and systems biology.
Ma X, Huang T, Li X, Zhou X, Pan H, Du A, Zeng Y, Yuan K, Wang Z. Ma X, et al. Front Med (Lausanne). 2024 Sep 20;11:1428973. doi: 10.3389/fmed.2024.1428973. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39371335 Free PMC article. - A matched case-control analysis of autonomous vs human-driven vehicle accidents.
Abdel-Aty M, Ding S. Abdel-Aty M, et al. Nat Commun. 2024 Jun 18;15(1):4931. doi: 10.1038/s41467-024-48526-4. Nat Commun. 2024. PMID: 38890354 Free PMC article. - _Anthriscus sylvestris_-Noxious Weed or Sustainable Source of Bioactive Lignans?
Berežni S, Mimica-Dukić N, Domina G, Raimondo FM, Orčić D. Berežni S, et al. Plants (Basel). 2024 Apr 12;13(8):1087. doi: 10.3390/plants13081087. Plants (Basel). 2024. PMID: 38674496 Free PMC article. Review. - Phytochemicals in Cancer Treatment and Cancer Prevention-Review on Epidemiological Data and Clinical Trials.
Rudzińska A, Juchaniuk P, Oberda J, Wiśniewska J, Wojdan W, Szklener K, Mańdziuk S. Rudzińska A, et al. Nutrients. 2023 Apr 14;15(8):1896. doi: 10.3390/nu15081896. Nutrients. 2023. PMID: 37111115 Free PMC article. Review. - Recent advance of herbal medicines in cancer- a molecular approach.
Ali M, Wani SUD, Salahuddin M, S N M, K M, Dey T, Zargar MI, Singh J. Ali M, et al. Heliyon. 2023 Feb 14;9(2):e13684. doi: 10.1016/j.heliyon.2023.e13684. eCollection 2023 Feb. Heliyon. 2023. PMID: 36865478 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical